Vendor, Blackburn North, AUS, part of Affinity Biosciences International Pty Ltd.
Myrio Therapeutics Pty Ltd.
UEI ZNWKZF5TAEU2, CAGE Z16B2
1 award and $51,836 obligated between January 18, 2024 and January 18, 2024, 0% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $51,836 |
How it wins
Awards by competition, set-aside and type.
| Competed Under SAP | 1 |
| Purchase Order | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N92024P00043Purchase Order, January 18, 2024, Competed Under SAP, 1 offers | National Institutes of Health NhlbiNational Institutes of Health | Bispecific Antibodies Against CT-RCC Herv-ENAICS 541715, PSC Q301 | $51,836 |
- Product and service codes
- Q301 Reference Laboratory Testing
- Transactions
- 1 across 1 awards